MICROSOMAL HYDROXYLATION AS MEASURED BY PENTOBARBITAL ELIMINATION IN PATIENTS WITH IDIOPATHIC SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:12
作者
DRAYER, DE
LORENZO, B
LAHITA, RG
ROBBINS, WC
REIDENBERG, MM
机构
[1] CORNELL UNIV, MED CTR, NEW YORK HOSP, COLL MED, DEPT MED, NEW YORK, NY 10021 USA
[2] ROCKEFELLER UNIV, NEW YORK, NY 10021 USA
[3] HOSP SPECIAL SURG, NEW YORK, NY 10021 USA
关键词
D O I
10.1038/clpt.1982.147
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:195 / 200
页数:6
相关论文
共 33 条
[1]  
ALARCONSEGOVIA D, 1969, MAYO CLIN PROC, V44, P664
[2]  
BALDEO W C, 1980, European Journal of Drug Metabolism and Pharmacokinetics, V5, P75
[3]   THEORETICAL BASIS FOR INTEREST IN ACETYLPROCAINAMIDE AND CLINICAL-EXPERIENCES WITH THIS NEW ANTI-ARRHYTHMIC AGENT [J].
DRAYER, D ;
KLUGER, J ;
REIDENBERG, M ;
LAHITA, R .
DRUG METABOLISM REVIEWS, 1979, 10 (02) :239-246
[4]  
DRAYER DE, 1977, CLIN PHARMACOL THER, V22, P251
[5]  
DVORCHIK BH, 1978, CLIN PHARMACOL THER, V23, P617
[6]   PHARMACOKINETICS AND DISTRIBUTION PROPERTIES OF PENTOBARBITAL IN HUMANS FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION [J].
EHRNEBO, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (07) :1114-1118
[7]   GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].
EVANS, DAP ;
MANLEY, KA ;
MCKUSICK, VA .
BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491
[8]   KINETIC EVALUATION OF THE PROPRANOLOL-QUINIDINE COMBINATION [J].
FENSTER, P ;
PERRIER, D ;
MAYERSOHN, M ;
MARCUS, FI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :450-453
[9]   EVIDENCE FOR THE BIOTRANSFORMATION OF PROCAINAMIDE TO A REACTIVE METABOLITE [J].
FREEMAN, RW ;
WOOSLEY, RL ;
OATES, JA ;
HARBISON, RD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1979, 50 (01) :9-16
[10]  
FREEMAN RW, 1981, DRUG METAB DISPOS, V9, P188